Medilabo RFP
Manufacturing · Japan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Umetada-cho Sanjo Chohju 24 bldg 4f, Kyo...Website
www.medilaborfp.comRevenue
$5.6 MillionIndustry
About Medilabo RFP
Medilabo RFP Org Chart
Is Medilabo RFP your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Medilabo RFP launches new products
Earning: See what the market has to say on Medilabo RFP recently announced quarterly report
Medilabo RFP, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Medilabo RFP is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Medilabo RFP
Funding: Get notified immidiatlly once Medilabo RFP has new funding data
Click to see if Medilabo RFP had a recent Job posting/layoffs
Check if Medilabo RFP has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Medilabo RFP as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Medilabo RFP is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medilabo RFP is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medilabo RFP.
Medilabo RFP Tech Stack
A closer look at the technologies used by Medilabo RFP
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medilabo RFP
Medilabo RFP, Inc. is a clinical-stage biopharmaceutical company based in Japan, with a US office in Boston, specializing in the development of repurposed small molecules aimed at restoring neuronal function and slowing neurodegeneration. The company focuses on innovative treatments for neurological diseases such as Alzheimer's, Parkinson's disease... Read More